60
Gan & Lee Pharmaceuticals.
603087.SS · SHH
¥77.35 +3.34% (+¥2.50)
1M +11.98%
Market Cap ¥46.3B
P/E Ratio 40.23x
Div. Yield -
ROE 9.90%
Bulios Fair Price
¥52.85
31.7% downside
Current Price
¥77.35
Undervalued Fair Value Overvalued
According to Bulios Fair Price, 603087.SS is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
5/9Valuation
21 /100
Expensive EV/EBITDA 44.36x
P/S 10.99x
P/B 3.95x
Growth
91 /100
Growing Book val. growth 6.65%
Rev. growth 33.26%
FCF growth N/A
Profitability
65 /100
Moderate Net margin 27.32%
Op. margin 19.70%
FCF margin 0.65%
Quality
45 /100
Average ROE 9.90%
ROA 8.99%
Asset turnover 0.33x
Debt
100 /100
Low Current ratio 6.91x
Net debt/EBITDA -2.34x
Debt/Equity 0.02x
Stability
40 /100
Moderate Rev. volatility 17.79%
EPS volatility 56.61%
Profitable years 3
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about 603087.SS
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Wei Chen
Employees
5,309
Headquarters
Beijing
Upcoming events
28 OCT
Earnings
Upcoming earnings report